Wash. Says Novartis Isn't Harmed By 340B Drug Pricing Law
By Nadia Dreid · May 11, 2026, 10:47 PM EDT
Washington is objecting to Novartis' attempt to block a state law that expands the discounts the drugmaker must provide under the federal 340B Drug Pricing Program, telling a federal court that worry about...
To view the full article, register now.